Alafi
Capital is a private venture capital firm that has been active in healthcare investing for over 25 years. Early- and mid-stage investments in the U.S. and Europe are
considered, with emphasis on product-oriented biotechnology, life science
technologies, imaging and diagnostics, and medical devices.
Included among Alafi Capital’s past successes are Amgen, Biogen, Molecular Devices, Tanox, Qiagen, Novocor, Sequenom, Oxford Glycosciences, and Applied Biosystems.